|
End-of-day quote
Taiwan S.E.
16/10/2026
|
5-day change | 1st Jan Change | ||
| 51.10 TWD | +2.51% |
|
-0.39% | -17.18% |
| 07/10 | EirGenix Submits European Marketing Application for Breast Cancer Biosimilar | MT |
| 10/09 | EirGenix Completes Capital Reduction Following RSA Write-Off | MT |
| Market Cap | 1.53TCr 47Cr 42Cr 39Cr 35Cr 67Cr 4.46TCr 68Cr 465.82Cr 182.64Cr 2.33TCr 176.53Cr 172.77Cr 7.43TCr | P/E 2026 * |
-33.6x | P/E 2027 * | 89.6x |
|---|---|---|---|---|---|
| Enterprise Value | 1.4TCr 43Cr 38Cr 36Cr 32Cr 61Cr 4.1TCr 62Cr 427.76Cr 167.72Cr 2.14TCr 162.11Cr 158.65Cr 6.82TCr | EV / Sales 2026 * |
9.51x | EV / Sales 2027 * | 6.16x |
| Free-Float |
59.34% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | +2.51% | ||
| 1 week | -0.39% | ||
| Current month | -4.31% | ||
| 1 month | -3.04% | ||
| 3 months | +13.94% | ||
| 6 months | +0.99% | ||
| Current year | -17.18% |
| 1 week | 48.95 |  | 52 |
| 1 month | 48.95 | | 54 |
| Current year | 40.15 | | 67.6 |
| 1 year | 40.15 | | 84.3 |
| 3 years | 40.15 | | 111 |
| 5 years | 40.15 | | 163.5 |
| 10 years | 21.55 | | 195 |
| Manager | Title | Age | Since |
|---|---|---|---|
Li Cheng Liu
CEO | Chief Executive Officer | - | 01/04/2013 |
Hsiu Chuan Yang
DFI | Director of Finance/CFO | - | 03/05/2016 |
Yu Wen Liu
PRN | Corporate Officer/Principal | - | 20/05/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
Cheng Yue Cheng
BRD | Director/Board Member | - | 14/06/2013 |
Hsiu Hui Chen
BRD | Director/Board Member | - | 13/09/2016 |
Li Cheng Liu
CHM | Chairman | - | 10/06/2022 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.51% | -0.39% | -27.31% | -44.52% | 47Cr | |
| +0.43% | +6.59% | +56.57% | +107.01% | 1,12000Cr | |
| +0.90% | -2.25% | +32.26% | +67.33% | 62TCr | |
| +0.71% | +3.24% | +24.33% | +91.20% | 50TCr | |
| -0.13% | +5.98% | +33.66% | +52.01% | 37TCr | |
| +0.52% | +0.24% | +72.13% | +43.10% | 36TCr | |
| -0.95% | +4.70% | +19.65% | +43.09% | 29TCr | |
| -1.98% | +3.73% | -0.89% | +17.28% | 26TCr | |
| -0.35% | +4.25% | +44.74% | +52.51% | 23TCr | |
| -0.75% | +3.32% | +27.18% | +96.05% | 19TCr | |
| Average | +0.09% | +3.18% | +28.23% | +52.51% | 39.41TCr | |
| Weighted average by Cap. | +0.13% | +3.52% | +39.33% | +73.50% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 147.4Cr 4.54Cr 4.04Cr 3.74Cr 3.41Cr 6.43Cr 431.17Cr 6.53Cr 45Cr 18Cr 225Cr 17Cr 17Cr 717.27Cr | 234.3Cr 7.22Cr 6.42Cr 5.95Cr 5.41Cr 10Cr 685.37Cr 10Cr 72Cr 28Cr 357.65Cr 27Cr 27Cr 1.14TCr |
| Net income | -46Cr -1.41Cr -1.25Cr -1.16Cr -1.06Cr -2Cr -133.97Cr -2.03Cr -14Cr -5.48Cr -70Cr -5.3Cr -5.19Cr -222.87Cr | 17Cr 53.01L 47.12L 43.68L 39.74L 74.99L 50Cr 76.19L 5.25Cr 2.06Cr 26Cr 1.99Cr 1.95Cr 84Cr |
| Net Debt | -124.7Cr -3.84Cr -3.42Cr -3.17Cr -2.88Cr -5.44Cr -364.77Cr -5.52Cr -38Cr -15Cr -190.35Cr -14Cr -14Cr -606.81Cr | -84Cr -2.58Cr -2.3Cr -2.13Cr -1.94Cr -3.65Cr -245.13Cr -3.71Cr -26Cr -10Cr -127.92Cr -9.69Cr -9.49Cr -407.79Cr |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 6589 Stock
Select your edition
All financial news and data tailored to specific country editions
